People with epilepsy should be priority for COVID-19 vaccine

30 Nov 2020

People with epilepsy should be included in the clinical risk group of people who should receive the COVID-19 vaccine early, according to provisional guidance from the government’s Green Book. The Green Book has the latest information on vaccines for infectious diseases in the UK.

This guidance is subject to approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of the vaccine supply.

According to the document, published on 27 November, the vaccine will be given to different groups in order of priority. Older care home residents and staff working in care homes, health and social care workers and people aged 70 plus, will be prioritised initially. People considered clinically extremely vulnerable will be next, followed by people aged 65 and over.

People aged 18-65 with chronic neurological diseases, including epilepsy, should be included in the next priority group.

As well as epilepsy, chronic neurological diseases include stroke, cerebral palsy, severe learning disability, Down’s syndrome, dementia and Parkinson’s disease, among others.

The Green Book also says the vaccine should be given for neurological conditions in which breathing and respiration may be affected. People with genetic diseases of the muscles or nervous system that get worse with age, or those with severe neurological disability, should also be in this priority group.

Simon Wigglesworth, deputy chief executive at Epilepsy Action, said: “We understand the concern that the risk to people with epilepsy from COVID-19 is higher than we previously thought. However, we are pleased that this risk has now been identified and that people with epilepsy will be prioritised for the vaccine, subject to MHRA approval. We want to reassure people that we will continue to monitor and update the situation. In the meantime, if anyone has any concerns please contact our helpline on 0808 800 5050.”

Full details of the provisional guidance on the COVID-19 vaccine are available on the website.

There is more information on COVID-19 and epilepsy on the Epilepsy Action website.


You may also be interested in...

People with epilepsy at slightly increased risk of more severe COVID-19 symptoms, study suggests

There is a slightly increased risk of hospital admission and death from COVID-19 in people with epilepsy,according to a new study in the British Medical Journal (BMJ).

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
6 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.